Merck | MRK - Себестоимость





Себестоимость Изменить Дата
Adidas EUR 3.22B 235M 2026-03
Adyen EUR 226.65M 10M 2025-12
Akzo Nobel EUR 1.5B 95M 2026-06
Alcon AG USD 1.18B 26M 2026-03
Amadeus IT EUR 589.5M 51.6M 2026-03
Amarin USD 26.05M 1.41M 2025-12
AstraZeneca USD 2.52B 2.73B 2026-06
BASF EUR 11.87B 941M 2026-03
Bayer EUR 5.23B 731M 2026-03
Beiersdorf EUR 2.06B 50M 2025-12
Covestro EUR 2.7B 5.39B 2025-12
Danone EUR 6.73B 17M 2025-12
Fresenius EUR 4.45B 262M 2025-12
Fresenius Medical Care EUR 3.43B 248M 2026-03
Genmab DKK 81M 23M 2025-12
Givaudan CHF 2.07B 105M 2025-12
GlaxoSmithKline GBP 2.07B 192M 2026-06
GRIFOLS EUR 1.08B 214.82M 2026-03
Henkel EUR 4.96B 110M 2025-12
Hikma Pharmaceutical USD 959M 492.5M 2025-12
Infineon EUR 2.34B 136M 2026-03
Lakefront Biotherapeutics EUR 4.8M 4.34M 2026-03
Linde USD 4.52B 974M 2026-03
Lonza CHF 2.28B 189M 2025-06
Merck EUR 2.07B 219M 2026-03
Novartis USD 3.71B 251M 2026-06
Philips EUR 2.21B 70M 2026-06
Roche Holding CHF 7.85B 630M 2026-06
Sanofi EUR 3.67B 621M 2026-03
UCB EUR 1.07B 146M 2025-12